PTGS2 and colorectal carcinoma: Previous studies have report that prostaglandin could promote CRC occurrence and progression, and inhibition of prostaglandin with COX-2 selective inhibitors or non-steroidal anti-inflammatory drugs (NSAIDs) could prevention of CRC (27, 28).